IBIO (IBIO) Stock Price & Analysis
IBIO (IBIO) rose 0.77% to USD 1.31 as of September 8, 2026 at 05:45 UTC, according to Nexqual real-time market data.
IBIO last closed at USD 1.31; the session ranged USD 1.28–1.33 on volume of 265,443 shares. Market capitalization is —, with a 52-week range of USD 0.77–3.82 (NCM). Source: Nexqual, September 8, 2026 at 05:45 UTC.
Key Statistics (as of September 8, 2026 at 05:45 UTC)
| Price | USD 1.31 |
|---|---|
| Change | ▲ 0.77% (up) |
| Previous Close | USD 1.31 |
| Open | USD 1.31 |
| Day Range | USD 1.28 – 1.33 |
| 52-Week Range | USD 0.77 – 3.82 |
| Volume | 265,443 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (IBIO)
Nexqual's technical model rates IBIO "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:45 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.95 (neutral) |
| vs SMA50 | Below (USD 1.45) |
| MACD | -0.04 (negative) |
From IBIO's Latest SEC 10-K Filing (filed 2026-08-28)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VXRT | Vaxart, Inc. | USD 0.5 | ▲ 2.04% |
| TNXP | Tonix Pharmaceuticals Holding C | USD 13.14 | ▼ 1.79% |
| CODX | Co-Diagnostics, Inc. | USD 1.16 | ▲ 0% |
| INO | Inovio Pharmaceuticals, Inc. | USD 1.43 | ▲ 5.15% |
| SRNE | Sorrento Therapeutics, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:45 UTC. This page is informational and not investment advice.